a public good project by the
Synthesis
Company
of California

© 2026

Nico Wulffraat | doi.page

0 works0 citations0 h-index

Nico Wulffraat

Utrecht University(NL)University Medical Center Utrecht(NL)University Medical Center Utrecht(NL)

Publications by Year

Research Areas

Autoimmune and Inflammatory Disorders Research, Adolescent and Pediatric Healthcare, Immunodeficiency and Autoimmune Disorders, Acute Lymphoblastic Leukemia research, Kawasaki Disease and Coronary Complications

Most-Cited Works

→ Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome(2000)946 cited
→ Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis(2012)855 cited
→ 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases(2019)779 cited
→ 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative(2015)750 cited
→ Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis(2012)698 cited
→ EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases(2010)630 cited

→ Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus(2018)524 cited

→ Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?(2010)427 cited

→ A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis(2007)408 cited

→ 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis(2016)387 cited